Electrospinning of nanofiber fibrinogen structuresWNEK, Gary E; CARR, Marcus E; SIMPSON, David G et al.Nano letters (Print). 2003, Vol 3, Num 2, pp 213-216, issn 1530-6984, 4 p.Article

Control of Anti-Thrombogenic Properties: Surface-Induced SelfAssembly of Fibrinogen FibersKOO, Jaseung; GALANAKIS, Dennis; YING LIU et al.Biomacromolecules. 2012, Vol 13, Num 5, pp 1259-1268, issn 1525-7797, 10 p.Article

The sequence γ-(312-324) is a fibrin-specific epitopeSCHIELEN, W. J. G; ADAMS, H. P. H. M; VAN LEUVEN, K et al.Blood. 1991, Vol 77, Num 10, pp 2169-2173, issn 0006-4971Article

A hereditary dysfibrinogenemia; fibrinogen AwajiMATSUO, T; OKUNO, S; MUKAIDA, T et al.Haemostasis. 1987, Vol 17, Num 1-2, pp 89-97, issn 0301-0147Article

Conformational behavior of fibrinogen on topographically modified polymer surfacesLI BUAY KOH; RODRIGUEZ, Isabel; VENKATRAMAN, Subbu S et al.PCCP. Physical chemistry chemical physics (Print). 2010, Vol 12, Num 35, pp 10301-10308, issn 1463-9076, 8 p.Article

Novel γ230 Asn→Asp substitution in fibrinogen Middlemore associated hypofibrinogenaemiaBRENNAN, Stephen O; SHEEN, Campbell R; GEORGE, Peter M et al.Thrombosis and haemostasis. 2005, Vol 93, Num 6, pp 1196-1197, issn 0340-6245, 2 p.Article

Fibrinogen nottingham II: A novel BβArg264gly substitution causing hypofibrinogenaemiaHILL, Marian B; BRENNAN, Stephen O; DEAR, Amy et al.Thrombosis and haemostasis. 2006, Vol 96, Num 3, pp 378-380, issn 0340-6245, 3 p.Article

Adjacent substitutions (γ352Gly→Cys and 353Thr→Pro) in fibrinogen Ilam cause diminished y chain expressionBRENNAN, Stephen O; OLIVER, Jocelyn; DAVIS, Ryan L et al.Thrombosis and haemostasis. 2011, Vol 105, Num 2, pp 379-381, issn 0340-6245, 3 p.Article

Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloidsFENGER-ERIKSEN, C; TONNESEN, E; INGERSLEV, J et al.Acta anaesthesiologica scandinavica. 2009, Vol 53, Num 3, pp 332-338, issn 0001-5172, 7 p.Article

Fibrinogen binding to human blood platelets: effect of γ chain carboxyterminal structure and lengthPEERSCHKE, E. I. B; FRANCIS, C. W; MARDER, V. J et al.Blood. 1986, Vol 67, Num 2, pp 385-390, issn 0006-4971Article

Fibrinogen, fibrinogen receptors, and the peptides that inhibit these interactionsPLOW, E. F; MARGUERIE, G; GINSBERG, M et al.Biochemical pharmacology. 1987, Vol 36, Num 23, pp 4035-4040, issn 0006-2952Article

Fibrinogen prepared from small blood samples for autologous use in a tisoue adhesive systemSIVERTSEN WEIS-FOGH, U.European surgical research. 1988, Vol 20, Num 5-6, pp 381-389, issn 0014-312XArticle

Novel fibrinogen (Bβ401Gly→Val) presents as dys- or hypodysfibrinogenaemia due to alterations in sialic acid contentBRENNAN, Stephen O; RONCOLATO, Fernando.Thrombosis and haemostasis. 2011, Vol 106, Num 3, pp 551-553, issn 0340-6245, 3 p.Article

Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilutionSCHRAMKO, A. A; KUITUNEN, A. H; SUOJARANTA-YLINEN, R. T et al.Acta anaesthesiologica scandinavica. 2009, Vol 53, Num 6, pp 731-735, issn 0001-5172, 5 p.Article

Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven®) and Fibrinogen (Haemocomplettan® P)TANAKA, Kenichi A; TAKETOMI, Taro; SZLAM, Fania et al.Anesthesia and analgesia. 2008, Vol 106, Num 3, pp 732-738, issn 0003-2999, 7 p.Article

Fibrinogen Tolaga bay : A novel γala341Val mutation causing hypofibrinogenaemiaDAVIS, Ryan L; BRENNAN, Stephen O.Thrombosis and haemostasis. 2007, Vol 98, Num 5, pp 1136-1138, issn 0340-6245, 3 p.Article

Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIICYAZER, Mark H; TRIULZI, Darrell J; CORTESE HASSETT, Andrea et al.Transfusion (Philadelphia, PA). 2010, Vol 50, Num 5, pp 1014-1018, issn 0041-1132, 5 p.Article

Fibrinogen Giessen. I: A congenital homozygously expressed dysfibrinogenemia with Aα 16 Arg→His substitutionALVING, B. M; HENSCHEN, A. H.American journal of hematology. 1987, Vol 25, Num 4, pp 479-482, issn 0361-8609Article

Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adultsWARMUTH, M; MAD, P; WILD, C et al.Acta anaesthesiologica scandinavica. 2012, Vol 56, Num 5, pp 539-548, issn 0001-5172, 10 p.Article

Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished y chain expression and increased sialic acid contentBRENNAN, Stephen O; DAVIS, Ryan L.Thrombosis and haemostasis. 2010, Vol 104, Num 6, pp 1274-1276, issn 0340-6245, 3 p.Article

Fibrinogen in children undergoing cardiac surgery: Is it effective?MILLER, Bruce E; TOSONE, Steven R; GUZZETTA, Nina A et al.Anesthesia and analgesia. 2004, Vol 99, Num 5, pp 1341-1346, issn 0003-2999, 6 p.Article

Characterization of adhesion of non-exogenously stimulated and resting platelets in normal plasma to fibrinogen and its fragmentsGARTNER, T. K; AMRANI, D. L; DERRICK, J. M et al.Blood coagulation & fibrinolysis. 1994, Vol 5, Num 5, pp 747-754, issn 0957-5235Conference Paper

Irreversible platelet fibrinogen interactions occur independently of fibrinogen alpha chain degradation and are not mediated by intact platelet membrane glycoprotein IIb-IIIa complexesPEERSCHKE, E. I. B.The Journal of laboratory and clinical medicine. 1988, Vol 111, Num 1, pp 84-92, issn 0022-2143Article

Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulationRODEGHIERO, F; CASTAMAN, G. C; DAL BELIN PERUFFO, A et al.Thrombosis and haemostasis. 1987, Vol 57, Num 3, pp 252-258, issn 0340-6245Article

Platelet aggregation by fibrinogen polymers crosslinked across the E domainMCMANAMA, G; LINDON, J. N; KLOCZEWIAK, M et al.Blood. 1986, Vol 68, Num 2, pp 363-371, issn 0006-4971Article